Search

Trump calls FBI search 'unannounced raid on my home' Sources said the FBI’s search warrant was approved by a federal judge in relation to an investigation into former President Donald Trump’s alleged mishandling of classified information. January 6 Investigation: Robbins Appears on ABC News to...

DOJ has multiple possible paths to Trump indictment: Here’s what it could look like BY HARPER NEIDIG AND REBECCA BEITSCH - 07/27/22 4:56 PM ET Jeff Robbins, a former federal prosecutor and congressional investigative counsel, said he believes the committee’s hearings have likely prompted the renewed...

Steve Bannon showed ‘monumental arrogance’: Former prosecutor ABC News’ Phil Lipof spoke with Jeffrey Robbins, former chief counsel for the minority of the U.S. Senate Permanent Subcommittee on Investigations, about Steve Bannon being found guilty of contempt. January 6 Investigation: Robbins...

Jan. 6 committee to hold Thursday prime-time hearing The Jan. 6 committee said Thursday’s hearing will focus on the 187 minutes between former President Donald Trump’s speech at his rally and public statement trying to quell the riot. January 6 Investigation: Robbins Appears on ABC News to Discuss...

ABC News Live: Jan. 6 committee focuses on efforts to pressure states Plus, the latest on the investigation into the school shooting in Uvalde, Texas. January 6 Investigation: Robbins Appears on ABC News Live to Discuss the Committee's Focus on Trump's Efforts to Pressure State Elections.

Christie McGuinness focuses her practice on commercial litigation and disputes involving force majeure and white collar and government enforcement. Christie represents clients in a wide range of industries in cases alleging breach of contract and breach of fiduciary duty as well as disputes arising...

The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...

Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...

Sunu Pillai counsels construction and energy industry clients on issues throughout the project life-cycle, from contract formation through dispute resolution. Having worked in the construction industry as an engineer, project manager and claims consultant prior to his legal career, Sunu has a deep...

Sarah Sullivan represents pharmaceutical companies involved in complex, high stakes patent litigation. Sarah concentrates her practice on Hatch-Waxman ANDA cases and disputes over the intellectual property behind branded pharmaceuticals. She is part of the Firm's nationally-recognized team for...

Saul Ewing attorneys understand the risks companies and individuals face when their intellectual property and brand are threatened, and we have deep experience helping clients protect their IP rights when disputes escalate to litigation. Our attorneys handle a variety of IP litigation cases across a...

Saul Ewing’s Litigation Department features approximately 200 attorneys across 18 offices. We handle a wide range of matters including complex business and commercial disputes, bet-the-company legal proceedings, and high-profile cases in state and federal courts and Alternative Dispute Resolution...

Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...

Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...

Jim Taylor is a trial lawyer with first-chair experience handling complex litigation in federal and state courts. A significant portion of his practice uses that litigation experience and perspective to counsel clients in managing high-profile crises, minimizing financial and reputational risks...

Alex Callo represents clients in high stakes intellectual property litigation, with a specific focus on complex pharmaceutical patent litigation under the Hatch-Waxman Act. His experience includes drafting motions and pleadings, research, and analyzing discovery. Alex has a background in both...

Bill Baton represents pharmaceutical companies in complex, often high-profile, patent litigation. Bill concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical companies. He currently serves as New Jersey litigation counsel in more...

Eric Orlinsky co-chairs the firm's Corporate Practice and its Private Equity/Venture Capital subgroup and concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity...